Dr. Rohan Kalyan Rej received his Ph.D. in organic chemistry from the Indian Institute of Technology Kharagpur, India in 2015, followed by a postdoctoral fellowship at Purdue University, USA (2015–2016) and the University of Michigan, USA (2016–2020). He is currently a research-track faculty member at the University of Michigan, USA. His research interests mainly focus on the design and synthesis of novel anticancer drugs along with PROTAC degraders against different proteins.